7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

C17H17N5O4 — CID 167752083

IUPAC7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
SMILESO=C1CNC(=O)c2cc(C(=O)N3CCC(c4cc(=O)[nH][nH]4)C3)ccc2N1
InChIInChI=1S/C17H17N5O4/c23-14-6-13(20-21-14)10-3-4-22(8-10)17(26)9-1-2-12-11(5-9)16(25)18-7-15(24)19-12/h1-2,5-6,10H,3-4,7-8H2,(H,18,25)(H,19,24)(H2,20,21,23)
InChIKeyCPWJNRXBCRLENX-UHFFFAOYSA-N
MW355.35 g/mol
LogP0.01
Rot. Bonds2

About 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione (PubChem CID 167752083) has the molecular formula C17H17N5O4 and a molecular weight of 355.35 g/mol. Its IUPAC name is 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione.

Molecular Properties

Compound Name7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
PubChem CID167752083
Molecular FormulaC17H17N5O4
Molecular Weight355.35 g/mol
Exact Mass355.13
IUPAC Name7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
SMILESO=C1CNC(=O)c2cc(C(=O)N3CCC(c4cc(=O)[nH][nH]4)C3)ccc2N1
InChIInChI=1S/C17H17N5O4/c23-14-6-13(20-21-14)10-3-4-22(8-10)17(26)9-1-2-12-11(5-9)16(25)18-7-15(24)19-12/h1-2,5-6,10H,3-4,7-8H2,(H,18,25)(H,19,24)(H2,20,21,23)
InChIKeyCPWJNRXBCRLENX-UHFFFAOYSA-N
XLogP0.01
TPSA127.16 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.35
LogP ≤ 50.01
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Analyze 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione?
The IUPAC name of 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione (CID 167752083) is 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione.
What is the SMILES notation for 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione?
The canonical SMILES for 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione is O=C1CNC(=O)c2cc(C(=O)N3CCC(c4cc(=O)[nH][nH]4)C3)ccc2N1.
What is the InChIKey of 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione?
The InChIKey is CPWJNRXBCRLENX-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17N5O4/c23-14-6-13(20-21-14)10-3-4-22(8-10)17(26)9-1-2-12-11(5-9)16(25)18-7-15(24)19-12/h1-2,5-6,10H,3-4,7-8H2,(H,18,25)(H,19,24)(H2,20,21,23).
What are the key properties of 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione?
7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione has a molecular weight of 355.35 g/mol, XLogP of 0.01, 2 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[3-(5-oxo-1,2-dihydropyrazol-3-yl)pyrrolidine-1-carbonyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione is sourced from PubChem (CID 167752083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).